ATLASViking Therapeutics (VKTX) earnings date: expected January 10–16
Viking Therapeutics (VKTX) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 10–16. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on VKTX
| Last price | $27.28 (+1.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.7% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Viking Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 10–16 (estimate). One email the day before, with ATLAS’s read on Viking Therapeutics. You can switch it off at any time.
Alert me before VKTX reportsFree to start. Creating an account takes under a minute.
VKTX earnings at a glance
| Next report | Not announced · expected around January 10–16 (ATLAS estimate) |
|---|---|
| Last report | Oct 28, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -47.8% |
| Average move around a report | ±3.1% (last 4) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Viking Therapeutics’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Viking Therapeutics earnings history: last 5 reports
Viking Therapeutics last reported on Oct 28, 2026: EPS of -$1.55 against an estimate of $1.00 (-255.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 28, 2026 | $1.00 | -$1.55 | -255.0% | Miss | – |
| Jul 28, 2026 | $0.87 | $0.89 | +2.3% | Beat | -4.1% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | -2.9% |
| Apr 29, 2026 | -$0.91 | -$1.37 | -50.6% | Miss | -3.7% |
| Mar 13, 2026 | $0.05 | $0.07 | +40.0% | Beat | +1.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for VKTX
See the fair value, the probability range and the earnings history of Viking Therapeutics on its ATLAS page.
Viking Therapeutics (VKTX) stock analysisPlans from €3.99 a month.
Viking Therapeutics earnings: frequently asked questions
When is Viking Therapeutics (VKTX) next earnings date?
Viking Therapeutics has not announced its next report. Its last 4 reports came Oct 28, 2026, Jul 28, 2026, May 29, 2026, Mar 13, 2026, so ATLAS estimates the next one around January 10–16. This is an estimate based on that pattern, not a confirmed date.
How often does VKTX beat earnings estimates?
Of its last 5 reports with a recorded result, Viking Therapeutics beat the EPS estimate 3 times; the average surprise was -47.8%. Past results do not predict the next one.
How much does VKTX move around earnings?
Over its last 4 reports the stock moved an average of 3.1% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Viking Therapeutics beat earnings estimates last quarter?
Viking Therapeutics last reported on Oct 28, 2026: EPS of -$1.55 against an estimate of $1.00 (-255.0% surprise), a miss.
How much does VKTX usually move in a day?
On a normal trading day the ATLAS model puts VKTX’s one-day range at about ±4.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer